Immunogenicity and Cross-Protective Efficacy Induced by an Inactivated Recombinant Avian Influenza A/H5N1 (Clade 2.3.4.4b) Vaccine against Co-Circulating Influenza A/H5Nx Viruses

Controlling avian influenza viruses (AIVs) is mainly based on culling of the infected bird flocks or via the implementation of inactivated vaccines in countries where AIVs are considered to be endemic. Over the last decade, several avian influenza virus subtypes, including highly pathogenic avian in...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Sara H. Mahmoud, Ahmed A. Khalil, Noura M. Abo Shama, Marwa F. El Sayed, Reem A. Soliman, Naglaa M. Hagag, Nahed Yehia, Mahmoud M. Naguib, Abdel-Sattar Arafa, Mohamed A. Ali, Mounir M. El-Safty, Ahmed Mostafa
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2023-08-01
Sarja:	Vaccines
Aiheet:	highly pathogenic avian influenza immunogenicity vaccine AIV H5N1 AIV H5N8 clade 2.3.4.4b
Linkit:	https://www.mdpi.com/2076-393X/11/9/1397
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!